Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
03/18/2009 | CN101386596A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
03/17/2009 | US7504519 e.g. N-Methoxycarbonyl-4-(4,5-dihydro-5-phenyl-3-trifluoromethyl-pyrazole-1-yl)-benzenesulphonamide; antiinflammatory and analgesic agent |
03/17/2009 | US7504518 reacting a pyrazole compound with an ethylenically unsaturated group-containing isocyanate compound; no need to use any inert solvent such as toluene or xylene, safety to the human body and environment is excellent and the production processes and equipment can be simplified |
03/17/2009 | US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents |
03/17/2009 | US7504424 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
03/17/2009 | US7504362 Pesticidal compositions |
03/17/2009 | US7503965 Azo compound, ink composition, and colored object |
03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
03/12/2009 | US20090069572 Process for the preparation of pyrazoles |
03/12/2009 | US20090069571 Reacting 5-amino-1-phenylpyrazole with alkylthioalkyl chloride in presence of basic potassium salt and nitrile |
03/12/2009 | US20090069398 Pyrazolyl Carboxamides |
03/12/2009 | US20090069329 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
03/12/2009 | US20090069310 Anti-inflammatory medicaments |
03/12/2009 | US20090069288 Novel therapeutic compounds |
03/12/2009 | US20090069184 4-(4-trifluoromethyl-3-thiobenzoyl)pyrazoles and their use as herbicides |
03/12/2009 | CA2698742A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
03/11/2009 | EP2033955A1 Urea derivatives of 1H-pyrazol-4-carboxylic acid with neutrophil chemotaxis inhibiting activity |
03/11/2009 | EP2032535A1 Spirocyclic nitriles as protease inhibitors |
03/11/2009 | EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb |
03/11/2009 | CN101384556A Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound |
03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
03/11/2009 | CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
03/10/2009 | US7501527 Method for the production of fluoromethyl-substituted heterocycles |
03/10/2009 | US7501449 2H -or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof |
03/10/2009 | US7501446 3-(Pyrid-3-yl)-5-(thiophen-2-yl)-pyrazoles; prenyl-protein transferase inhibitors |
03/10/2009 | US7501444 3-Pyrid-3-yl- pyrazoles in which pyrazole ring is additionally substituted with a halogenated phenyl group; prenyl-protein transferase inhibitors |
03/05/2009 | WO2009029499A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
03/05/2009 | WO2009028727A1 Fluorine-containing organosulfur compound and pesticidal composition comprising the same |
03/05/2009 | WO2009028655A1 Heterocyclic compound and use thereof |
03/05/2009 | WO2009028543A1 Substituted pyrazole derivative |
03/05/2009 | WO2009028280A1 Pyrazolecarboxylic acid derivative, method for producing the same and bactericide |
03/05/2009 | WO2009026658A1 Ppar agonists |
03/05/2009 | WO2009010416A3 Inhibitors of 11b-hydroxysteroid dehydrogenase |
03/05/2009 | WO2008145681A3 Ccr2 receptor antagonists and uses thereof |
03/05/2009 | WO2008140338A4 New ionic pairs with (4-chloro-2-methylphenoxy)acetate and their syntheses |
03/05/2009 | WO2008129157A4 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers |
03/05/2009 | WO2008110846A3 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases |
03/05/2009 | US20090062552 Process for the preparation of a carboxamide derivative |
03/05/2009 | US20090062540 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
03/05/2009 | US20090062365 Pyrazoles for the Treatment of GERD and IBS |
03/05/2009 | US20090062364 Deuterium-enriched celecoxib |
03/05/2009 | US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same |
03/05/2009 | US20090056586 Yellow dye compound and ink composition comprising the same |
03/05/2009 | CA2697663A1 Substituted pyrazole derivative |
03/05/2009 | CA2697368A1 Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
03/04/2009 | EP2029550A2 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
03/04/2009 | EP2029549A2 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands |
03/04/2009 | EP2029548A1 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists |
03/04/2009 | EP2029547A1 Fxr agonists |
03/04/2009 | EP2029546A1 Aryl-substituted heterocycles, and use thereof |
03/04/2009 | EP2029530A1 Ethenyl carboxamide derivatives useful as microbiocides |
03/04/2009 | CN101379039A Carboxamides for controlling micro-organisms in plant and material protection |
03/04/2009 | CN101379036A Anthranilamide/2-amino-heteroarene carboxamide derivatives |
03/03/2009 | US7498436 Substituted hydroxyethylamines |
03/03/2009 | CA2393197C Control of arthropods in animals with 1-arylpyrazoles |
02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
02/26/2009 | WO2009024342A2 Novel microbiocides |
02/26/2009 | US20090054662 Process for synthesizing a substituted pyrazole |
02/26/2009 | US20090054661 Method for Producing Carboxamides |
02/26/2009 | US20090054660 Method for producing carboxamides |
02/26/2009 | US20090054496 N-[o-(cyclopropylcyclobutyl)phenyl]heterocyclecarboxamides, for use in agriculture or horticulture for controlling or preventing infestations of plants by phytopathogenic microorganisms, especially fungi. |
02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
02/26/2009 | US20090054444 2(R)-2-(4-cyclopropanesulfonylphenyl)-N-(1-methylpyrazol-3-yl)-3-((R)-3-oxocyclopentyl)propionamide, useful in the prophylaxis and treatment of hyperglycemia and diabetes; hypoglycemic and antidiabetic agents |
02/26/2009 | US20090054431 Novel heterocycle compounds |
02/26/2009 | US20090054430 Inhibitors of Protein Kinases |
02/26/2009 | US20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
02/26/2009 | US20090054401 Substituted bicyclic derivatives and use thereof |
02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
02/26/2009 | US20090054240 Heteroaroyl-substituted Alanines |
02/26/2009 | DE102007040243A1 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen 17beta-dehydrogenase type 1 Hydroxysteriod inhibitors for the treatment of hormone-dependent diseases |
02/25/2009 | EP2027119A2 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
02/25/2009 | EP2027113A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
02/25/2009 | EP2027095A1 Heteroaroyl-substituted alanines with a herbicidal action |
02/25/2009 | EP2026799A2 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
02/25/2009 | CN101374816A Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds |
02/25/2009 | CN101374810A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
02/25/2009 | CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
02/25/2009 | CN101372476A Method for synthesizing pyrazole heterocycle without catalyst or solvent |
02/24/2009 | US7495023 treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis; also inhibiting cathepsins B and L to treat cancer; e.g. 3'-Bromopropiophenone Thiosemicarbazone |
02/24/2009 | US7495017 3-(3-Cyclopentyloxy-4-methoxyphenyl)-1H-pyrazole;adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease |
02/24/2009 | US7495015 Inhibitors of p38 Mitogen-activated protein kinases (MAP kinases); arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, chronic obstructive pulmonary disease, Alzheimer's disease; 6-(2-Fluoro-phenoxy)-3-phenyl-1H-indazole for example |
02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
02/24/2009 | CA2297406C Tricyclic vasopressin agonists |
02/19/2009 | WO2009023653A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
02/19/2009 | WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists |
02/19/2009 | WO2009021747A2 Treatment of duchenne muscular dystrophy |
02/19/2009 | WO2008130630A3 Polymorphic form of rimonabant hydrochloride and processes for preparation thereof |
02/19/2009 | WO2008038143A3 Novel solid forms of rimonabant and synthetic processes for their preparation |
02/19/2009 | US20090048250 protein kinase inhibitors such as 6-[4-(5-Cyclopropyl-2H-pyrazol-3-ylamino)-quinazolin-2-ylamino]-1,2-dihydro-indazol-3-one, used for treating diabetes, infections, inflammatory, allergic, autoimmune, proliferative, viral and Alzheimer's diseases, or immunodeficiency, cardiovascular and bone disorders |
02/19/2009 | US20090048235 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
02/19/2009 | US20090048226 Inhibitors of caspases |
02/19/2009 | US20090048112 Novel Herbicides |
02/19/2009 | US20090044348 3-amino-2-{[(1E)-2-amino-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene]amino}-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one; 3-amino-4-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl) imino]cyclohexa-2,5-dien-1-ylidene}-N-methylmethanaminium perchlorate for coloring keratin fibers; leuco dye |
02/19/2009 | CA2696006A1 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
02/19/2009 | CA2694993A1 1,2-diamido-ethylene derivatives |
02/19/2009 | CA2685582A1 Treatment of duchenne muscular dystrophy |
02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
02/18/2009 | EP2025671A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |